- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
PE Triage Platform from RapidAI Receives FDA 510(k) Clearance
The new artificial intelligence-powered software reportedly helps detect central pulmonary embolism (PE) on computed tomography pulmonary angiogram (CTPA) images and streamlines communication among interventional teams to bolster treatment outcomes.
Could an emerging artificial intelligence (AI)-enabled triage platform facilitate earlier detection and treatment for people who suffer a pulmonary embolism (PE)?
The Rapid PE Triage & Notification product has garnered 510(k) clearance from the Food and Drug Administration (FDA), according to the product’s manufacturer RapidAI.
The AI-enabled platform reportedly offers a variety of key benefits in the diagnosis and treatment of PE.
• Enhanced identification of suspected central PE on computed tomography pulmonary angiogram (CTPA) images
• Real-time notification with previews of CTPA imaging available for review via mobile devices, desktop computers and laptops
• Streamlined communication among interventional teams to facilitate triage of priority cases and timely treatment
“I’m excited to see firsthand how artificial intelligence will transform the way we triage and manage PE, a historically complicated process involving a diverse care team,” noted Jimmy Kerrigan, MD, FSCAI, FACC, RPVI, an interventional cardiologist affiliated with Ascension Saint Thomas Heart at multiple locations in Tennessee. “After seeing what RapidAI technology has done for stroke, I’m optimistic about about its potential to optimize our care for patients and to hopefully improve patient outcomes.”
Study Assesses Potential of Seven-Minute AI-Enhanced 3T MRI of the Shoulder
February 20th 2025Researchers found that the use of seven-minute threefold parallel imaging-accelerated deep learning 3T MRI had 89 percent sensitivity for supraspinatus-infraspinatus tendon tears and 93 percent sensitivity for superior labral tears.
Study Explores Impact of Insurance on Treatment and Referrals for Patients with Uterine Fibroids
February 19th 2025Women with uterine fibroids and Medicaid coverage are significantly more likely to be treated with uterine artery embolization than those with commercial insurance, according to newly published research.
Study: AI Boosts Ultrasound AUC for Predicting Thyroid Malignancy Risk by 34 Percent Over TI-RADS
February 17th 2025In a study involving assessment of over 1,000 thyroid nodules, researchers found the machine learning model led to substantial increases in sensitivity and specificity for estimating the risk of thyroid malignancy over traditional TI-RADS and guidelines from the American Thyroid Association.
